1716P Vigil plasmid (VP), a dual bi-shRNA-furin/GMCSF construct from cancer to SARS-CoV-2

por Jay, C., Stanbery, L., Kerneis, F., Nemunaitis, J., Aaron, P., Manning, L., Wallraven, G., Shanahan, D., Shen, Y., Senzer, N., Bognar, E.
Publicado 2020

A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis

por Santoro, A, Simonelli, M, Rodriguez-Lope, C, Zucali, P, Camacho, L H, Granito, A, Senzer, N, Rimassa, L, Abbadessa, G, Schwartz, B, Lamar, M, Savage, R E, Bruix, J
Publicado 2013

A multicenter phase 1 study of PX-866 in combination with docetaxel in patients with advanced solid tumours

por Bowles, D W, Ma, W W, Senzer, N, Brahmer, J R, Adjei, A A, Davies, M, Lazar, A J, Vo, A, Peterson, S, Walker, L, Hausman, D, Rudin, C M, Jimeno, A
Publicado 2013